The Drexel News Blog checked in with Paul W. Brandt-Rauf, ScD, MD, DrPH, a distinguished university professor and dean of the School of Biomedical Engineering, Science and Health Systems, who has studied peptide therapies for treatment and prevention of cancer, to ask him about the potential for peptides and possible safety risks.